Cargando…

Analysis of interleukin-13 receptor alpha2 expression as a prognostic biomarker in surgically resected pancreatic cancer patients

Detalles Bibliográficos
Autores principales:	Fujisawa, Toshio, Shimamura, Takeshi, Joshi, Bharat H, Puri, Raj K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645977/ http://dx.doi.org/10.1186/2051-1426-3-S2-P88

Ejemplares similares

Interleukin 13 receptor alpha 2 directed immunotherapy targets hepatic fibrosis and tumorigenesis induced by choline deficient diet in an in vivo mouse model of nonalcoholic steatohepatitis
por: Fujisawa, Toshio, et al.
Publicado: (2014)

Histone deacetylase inhibitiors enhance sensitivity of murine sarcoma tumors to IL-13-PE immunotoxin-based cancer therapy by upregulating IL-13Rα2 expression in vitro and in vivo
por: Fujisawa, Toshio, et al.
Publicado: (2013)

A Novel Role of Interleukin 13 Receptor alpha2 in Perineural Invasion and its Association with Poor Prognosis of Patients with Pancreatic Ductal Adenocarcinoma †
por: Fujisawa, Toshio, et al.
Publicado: (2020)

Generation of interleukin-13 receptor alpha2 antigen expressing modified vaccinia ankara recombinant virus for potential cancer immunotherapy
por: Sato, Yuki, et al.
Publicado: (2014)

Histone modification enhances the effectiveness of IL-13 receptor targeted immunotoxin in murine models of human pancreatic cancer
por: Fujisawa, Toshio, et al.
Publicado: (2011)

IL-13Rα2 Is a Biomarker of Diagnosis and Therapeutic Response in Human Pancreatic Cancer
por: Fujisawa, Toshio, et al.
Publicado: (2021)

Interleukin-13 receptor α2 DNA prime boost vaccine induces tumor immunity in murine tumor models
por: Nakashima, Hideyuki, et al.
Publicado: (2010)

Interleukin-4 receptor targeted immunotherapy of human bladder cancer in animal models
por: Joshi, Bharat H, et al.
Publicado: (2014)

Interleukin-4 receptor alpha overexpression in human bladder cancer correlates with the pathological grade and stage of the disease
por: Joshi, Bharat H, et al.
Publicado: (2014)

Identification of a novel role of IL-13Rα2 in human Glioblastoma multiforme: interleukin-13 mediates signal transduction through AP-1 pathway
por: Bhardwaj, Rukmini, et al.
Publicado: (2018)

Cysteamine Suppresses Invasion, Metastasis and Prolongs Survival by Inhibiting Matrix Metalloproteinases in a Mouse Model of Human Pancreatic Cancer
por: Fujisawa, Toshio, et al.
Publicado: (2012)

Sputum interleukin (IL)-13 as a biomarker for the evaluation of asthma control
por: Tsilogianni, Zoi, et al.
Publicado: (2015)

Pyruvate kinase M2 may be a therapeutic target in a mouse model of human non-small cell lung cancer
por: Suzuki, Akiko, et al.
Publicado: (2015)

Circulating immune cells in patients with surgically resected nonfunctional pancreatic neuroendocrine tumors
por: Jutric, Zeljka, et al.
Publicado: (2015)

Desmogleins as prognostic biomarkers in resected pancreatic ductal adenocarcinoma
por: Ormanns, Steffen, et al.
Publicado: (2015)

Potential prognostic biomarkers in pancreatic juice of resectable pancreatic ductal adenocarcinoma
por: Agrawal, Shefali
Publicado: (2017)

Loss of Interleukin-13-Receptor-Alpha-1 Induces Apoptosis and Promotes EMT in Pancreatic Cancer
por: Shi, Jingwei, et al.
Publicado: (2022)

Identification and Validation of Circulating Micrornas as Prognostic Biomarkers in Pancreatic Ductal Adenocarcinoma Patients Undergoing Surgical Resection
por: Gablo, Natalia, et al.
Publicado: (2020)

Influence of Interleukin-4 and Interleukin-13 on serum immunoglobulin E in house dust mite allergy
por: Panaitescu, Carmen, et al.
Publicado: (2014)

Phase I trial of systemic intravenous infusion of interleukin-13-Pseudomonas exotoxin in patients with metastatic adrenocortical carcinoma
por: Liu-Chittenden, Yi, et al.
Publicado: (2015)

Interleukin-13 Receptor Alpha 2-Targeted Glioblastoma Immunotherapy
por: Sengupta, Sadhak, et al.
Publicado: (2014)

Over-Expression of Alpha-Enolase as a Prognostic Biomarker in Patients with Pancreatic Cancer
por: Sun, Lichao, et al.
Publicado: (2017)

Prognostic significance of XB130 expression in surgically resected pancreatic ductal adenocarcinoma
por: Zhang, Jianli, et al.
Publicado: (2014)

Prognostic factors associated with early mortality after surgical resection for pancreatic adenocarcinoma
por: Kwak, Bong Jun, et al.
Publicado: (2014)

Clinicopathological and Prognostic Value of Survivin Expression in Surgically Resected Pancreatic Ductal Adenocarcinoma
por: Vay, Christian, et al.
Publicado: (2022)

Polymorphisms in the interleukin 4, interleukin 13 and corresponding receptor genes are not associated with Systemic Sclerosis and do not influence gene expression
por: Broen, JCA, et al.
Publicado: (2010)

Prognostic Analysis and Influencing Serum Biomarkers of Patients With Resectable Pancreatic Adenosquamous Cancer
por: Shi, Yusheng, et al.
Publicado: (2021)

Focus on Therapeutic Options for Surgically Resectable Pancreatic Adenocarcinoma Based on Novel Biomarkers
por: Olivari, Alessandro, et al.
Publicado: (2023)

Recent Advances in IL-13Rα2-Directed Cancer Immunotherapy
por: Knudson, Karin M., et al.
Publicado: (2022)

The Prognostic and Predictive Role of Epidermal Growth Factor Receptor in Surgical Resected Pancreatic Cancer
por: Guo, Meng, et al.
Publicado: (2016)

Prognostic Significance of Preoperative Neutrophil-to-Lymphocyte Ratio in Surgically Resectable Pancreatic Neuroendocrine Tumors
por: Zhou, Bo, et al.
Publicado: (2017)

Surgical resectability of pancreatic adenocarcinoma: CTA
por: Wong, Jimmie C., et al.
Publicado: (2009)

PANCREATIC NEUROENDOCRINE TUMORS: SURGICAL RESECTION
por: BELOTTO, Marcos, et al.
Publicado: (2019)

Integrated bioinformatics analysis shows integrin alpha 3 is a prognostic biomarker for pancreatic cancer
por: Hu, Fangfang, et al.
Publicado: (2022)

Mortality prognostic factors in acute pancreatitis
por: Popa, CC, et al.
Publicado: (2016)

Plasma Extracellular Vesicle Characteristics as Biomarkers of Resectability and Radicality of Surgical Resection in Pancreatic Cancer—A Prospective Cohort Study
por: Badovinac, David, et al.
Publicado: (2023)

Characterization of Chimeric Antigen Receptor Modified T Cells Expressing scFv-IL-13Rα2 after Radiolabeling with 89Zirconium Oxine for PET Imaging
por: Leland, Pamela, et al.
Publicado: (2023)

Characterization of chimeric antigen receptor modified T cells expressing scFv-IL-13Rα2 after radiolabeling with (89)Zirconium oxine for PET imaging
por: Leland, Pamela, et al.
Publicado: (2023)

Serum APN/CD13 as a novel diagnostic and prognostic biomarker of pancreatic cancer
por: Pang, Li, et al.
Publicado: (2016)

Interleukin-1-related cytokines as potential biomarkers in autoinflammatory skin diseases
por: Bonnekoh, H, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_hcp7j3aimbgd2nm0e1oaqahsk9